J Gynecol Oncol.  2022 Sep;33(5):e83. 10.3802/jgo.2022.33.e83.

Peritoneal dissemination of high-grade serous ovarian cancer: pivotal roles of chromosomal instability and epigenetic dynamics

Affiliations
  • 1Department of Obstetrics and Gynecology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan
  • 2Clinical Research Center, National Hospital Organization Kyoto Medical Center, Kyoto, Japan
  • 3Department of Gynecology and Obstetrics, Kyoto University Graduate School of Medicine, Kyoto, Japan
  • 4Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine, Morioka, Japan
  • 5Department of Obstetrics and Gynecology, Kindai University Faculty of Medicine, Osakasayama, Japan

Abstract

Epithelial ovarian cancer remains the lethal gynecological malignancy in women. The representative histotype is high-grade serous carcinoma (HGSC), and most patients with HGSC present at advanced stages with peritoneal dissemination. Since the peritoneal dissemination is the most important factor for poor prognosis of the patients, complete exploration for its molecular mechanisms is mandatory. In this narrative review, being based on the clinical, pathologic, and genomic findings of HGSC, chromosomal instability and epigenetic dynamics have been discussed as the potential drivers for cancer development in the fallopian tube, acquisition of cancer stem cell (CSC)-like properties, and peritoneal metastasis of HGSC. The natural history of carcinogenesis with clonal evolution, and adaptation to microenvironment of peritoneal dissemination of HGSC should be targeted in the novel development of strategies for prevention, early detection, and precision treatment for patients with HGSC.

Keyword

High-Grade Serous Ovarian Cancer; Peritoneal Dissemination; Chromosomal Instability; Epigenetic Dynamics; Cancer Stem Cell-Like Properties; Clonal Evolution
Full Text Links
  • JGO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr